title: Cytodifferentiation inducers as anticancer agents (review).
abstract: Several successful applications of differentiating agents in leukemic diseases, led to a regained interest in differentiation therapy. In this report we focus on novel classes of natural and synthetic compounds, which were not extensively reviewed and have a promising potential as anticancer agents e.g. protein kinase analogues, butyric acid, vitamin D-3 and purine and pyrimidine derivatives. The biological activities, preclinical and clinical studies of these agents are described.
authors: BASIL & GERALD FELSENSTEIN RES CTR,IL-49100 PETAH TIQWA,ISRAEL. TEL AVIV UNIV,ENDOCRINOL LAB,IL-69978 TEL AVIV,ISRAEL. TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL.
authors: A
authors: A
authors: Rephaeli
authors: J
authors: J
authors: Nordenberg